Evidence map›Paper›PMID 26569339›Full record

ArticleCellular signalling2016

Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication.

Biju Bhargavan, Shawna M Woollard, Georgette D Kanmogne

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. A Study ofGenes · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. HIV Latency in Myeloid Cells: Challenges for a Cure.Pathogens (Basel, Switzerland) · 2022
    Review
  7. Review
  8. C/EBPα Epigenetically ModulatesFrontiers in immunology · 2022
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Biju BhargavanDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800, USA. Electronic address: bbhargavan@unmc.edu.
Shawna M WoollardDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800, USA. Electronic address: swoollar@unmc.edu.
Georgette D KanmogneDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198-5800, USA. Electronic address: gkanmogne@unmc.edu.
University of Nebraska Medical Center · US

Funding

HIV Genetic Diversity and Viral NeuropathogenesisR01MH094160 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI KANMOGNE, GEORGETTE D. · 2012 to 2016
$3.1M
Blood brain barrier immune compromise in NeuroAIDSR01MH081780 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI KANMOGNE, GEORGETTE D. · 2008 to 2012
$1.5M
NIMH NIH HHS MH081780NIMH NIH HHS MH094160NIMH NIH HHS R01 MH081780NIMH NIH HHS R01 MH094160
6 · The paper itself

Abstract

TLR3 has been implicated in the pathogenesis of several viral infections, including SIV- and HIV-1-induced inflammation and AIDS. However the molecular mechanisms of these TLR3-mediated effects are not known, and it is not known whether HIV interacts with cellular TLR3 to affect disease process. Here we investigate the effects of TLR3 ligands on HIV-1 transactivation using both primary human macrophages and cells containing integrated copies of the HIV-1 promoter. We demonstrate that TLR3 activation induced upregulation of transcription factors such as c-Jun, CCAAT/enhancer-binding protein alpha (CEBPA), signal transducer and activator of transcription (STAT)-1, STAT-2, RELB, and nuclear factor kappa-B1 (NFκB1), most of which are known to regulate the HIV promoter activity. We also demonstrate that TLR3 activation increased HIV-1 transactivation via the c-Jun N-terminal kinase (JNK) and NFκB pathways. This was associated with epigenetic modifications, including decreased histone deacetylase activity, increased histone acetyl transferase (HAT) activity, and increased acetylation of histones H3 and H4 at lysine residues in the nucleosome-0 and nucleosome-1 of the HIV-1 promoter. However, prolonged TLR3 activation decreased HIV-1 transactivation, decreased HAT activity and Tat transcription, and suppressed viral replication. Overall, data suggests that TLR3 can act as viral sensor to mediate viral transactivation, cellular signaling, innate immune response, and inflammation in HIV-infected humans. Our study provides novel insights into the molecular basis for these TLR3-mediated effects.

Indexed as

Signal TransductionTranscriptional ActivationAcetylationCells, CulturedEpigenesis, GeneticGene Expression Regulation, ViralHistone AcetyltransferasesHistonesHIV-1HumansJNK Mitogen-Activated Protein KinasesMacrophagesMAP Kinase Signaling SystemNF-kappa BPromoter Regions, GeneticProto-Oncogene Proteins c-junHistone AcetyltransferasesHistonesJNK Mitogen-Activated Protein KinasesNF-kappa BProto-Oncogene Proteins c-juntat Gene Products, Human Immunodeficiency VirusToll-Like Receptor 3Transcription FactorsEpigeneticsHistone acetylationHIVHuman monocyte-derived macrophagesJNKLTRNFκBSTAT1TLR3TZM-blU38 cellsViral transactivation

Identifiers

PMID26569339
PMCPMC4890564
OpenAlexW2181247757

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.